Sélectionnez votre pays ou région

Vous êtes maintenant en Belgium (Français)

Sélectionnez votre pays ou région

Vous êtes maintenant en Belgium (Français)

Global

International (English)

Asia Pacific

Australia (English)
India (English)
Japan (日本語)
New Zealand (English)

Americas

Brazil (Português)
Canada (English)
Canada (Français)
USA (English)

Europe

Austria (Deutsch)
Belgium (Français)
Belgium (Nederlands)
Czech Republic (Česky)
Denmark (Dansk)
Finland (English)
France (Français)
Germany (Deutsch)
Ireland (English)
Italy (Italiano)
Norway (Norsk)
Poland (Polski)
Portugal (Português)
Spain (Español)
Sweden (Svenska)
Switzerland (Deutsch)
Switzerland (Français)
Switzerland (Italiano)
The Netherlands (Nederlands)
UK (English)

Africa

South Africa
Accueil / À propos d'Arjo / Investors / Newsroom
The share Arjo B 18 sept. 2024 17:29 3,84 EUR (+0,65%)

Newsroom

2021
Filtrer par:

jeudi 28 octobre 2021

Arjo interim report January-September 2021

”Our profitable growth continues in the third quarter with net sales growing over 5% organically and a nearly 35% increase in adjusted EBIT. We have also reached several important milestones in the commercialization of the new SEM Scanner in the quarter, including a contract with one of the largest GPOs in the US,” says Joacim Lindoff, President &...

Réglementation
Communiqués de presse
Arjo, President and CEO Joacim Lindoff
lundi 4 octobre 2021

Arjo announces date of 2021 Q3 report and conference call

Arjo will issue its Q3 report for 2021 on Thursday October 28 at 07:00 CET, followed by a conference call at 08:00 CET, hosted by Joacim Lindoff, President & CEO, and Daniel Fäldt, CFO.

Réglementation
Communiqués de presse
Arjo Logo
mercredi 15 septembre 2021

Arjo Receives Innovative Technology Contract from Vizient for the Provizio[® ]SEM Scanner

Arjo has been awarded an Innovative Technology Contract for the Provizio SEM Scanner with Vizient, Inc., the largest member-driven healthcare performance improvement company in the US. The contract further acknowledges the unique qualities of the Provizio SEM Scanner and its role in identification of pressure injury risk, which can help caregivers...

Communiqués de presse
Arjo Provizio® SEM Scanner
lundi 6 septembre 2021

Arjo receives 510(k) clearance from US FDA for WoundExpress

Arjo has received 510(k) clearance from the US Food and Drug Administration (FDA) for WoundExpress, an intermittent pneumatic compression (IPC) solution for accelerating healing of venous leg ulcers. The FDA clearance follows several recent studies showing that WoundExpress can significantly improve lower leg wound management.

Communiqués de presse
wound express -20 home flow Huntleigh CMYK
jeudi 15 juillet 2021

Arjo interim report January-June 2021

”We close another strong quarter and grow organically by 4,0%, supported by a solid order intake. We successfully navigate the Covid-19 challenges and see a continued recovery within profitable categories like patient handling, service and DVT. Our profitability continues to improve and we report an adjusted EBITDA-margin exceeding 23% for the...

Réglementation
Communiqués de presse
Arjo Provizio® SEM Scanner
mercredi 14 juillet 2021

Research establishes clear health-economic argument for including WoundExpress as standard care in the UK

A newly published research paper by Professor Julian Guest et al. shows that treating hard-to-heal venous leg ulcers with WoundExpress improves both clinical and financial outcomes. In combination with standard care, WoundExpress increased the probability of wound healing by 58% and improved the health-related quality of life for patients – with...

Communiqués de presse
Arjo WoundExpress Empowering Movement
mercredi 16 juin 2021

Arjo announces date of 2021 Q2 report and conference call

Arjo will issue its Q2 report for 2021 on Thursday July 15 at 07:00 CET, followed by a conference call at 08:00 CET, hosted by Joacim Lindoff, President & CEO, and Daniel Fäldt, CFO.

Réglementation
Communiqués de presse
Arjo Logo
mardi 27 avril 2021

Resolutions at Arjo’s Annual General Meeting 27 April 2021

Due to the corona pandemic and to limit the risk for spreading the virus, Arjo AB (publ) held the 2021 Annual General Meeting through electronic connection in accordance with the temporary law applicable during 2021. The shareholders could exercise their voting rights at the Meeting only by participating digitally or by postal voting in advance.

Réglementation
Communiqués de presse
Arjo Logo
mardi 27 avril 2021

Arjo interim report January-March 2021

“We close a strong first quarter where we continue to successfully navigate the Covid-19 challenges. We grow organically by 4,1%, with a strong profitability development where we report our highest gross margin for a single quarter to date, and our adjusted operating profit increases by 45% in comparable currencies. Our rental business grows by...

Réglementation
Communiqués de presse
Arjo Sara Flex
mercredi 7 avril 2021

Arjo announces date of 2021 Q1 report and conference call

Arjo will issue its Q1 report for 2021 on Tuesday April 27 at 07:00 CET, followed by a conference call at 08:00 CET, hosted by Joacim Lindoff, President & CEO, and Daniel Fäldt, CFO.

Réglementation
Communiqués de presse
Arjo Logo
jeudi 25 mars 2021

Arjo Annual Report 2020 – Mobility drives improved outcomes in healthcare

Today Arjo publishes the Annual Report for 2020. A success factor during the year was that Arjo navigated the short-term challenges in connection with the pandemic while capitalizing on new business opportunities and investing in the future. In 2020, Arjo also presented a new strategy for 2030 as well as a new sustainability framework.

Réglementation
Communiqués de presse
arjo president ceo joacim lindoff
mercredi 24 mars 2021

Wounds UK publishes consensus around IPC for treating venous leg ulcers – concluding positive results for WoundExpress™

Treating venous leg ulcers is a significant and costly challenge for healthcare. Now 8 experienced UK clinicians collaborate to form a consensus paper, published by Wounds UK, stating that the use of IPC solutions, in particular Arjo’s WoundExpress, can improve both clinical and financial outcomes.

Communiqués de presse
wound express -20 home flow Huntleigh CMYK
lundi 22 mars 2021

NOTICE OF ANNUAL GENERAL MEETING IN ARJO AB

The shareholders of Arjo AB (publ), Corporate ID No. 559092-8064, are hereby invited to attend the Annual General Meeting on Tuesday, April 27, 2021 at 15.00.

Réglementation
Communiqués de presse
Arjo Logo
mercredi 3 février 2021

Arjo publishes year-end report January-December 2020

”We put a very strong quarter and year behind us where we have adapted the business to the current circumstances, and supported healthcare in a challenging period. At the same time, we have exceeded all of the targets that we set at the beginning of the year. The Group grows organically by more than 4% in the fourth quarter with our adjusted...

Réglementation
Communiqués de presse
Arjo PIP scanner
vendredi 15 janvier 2021

Arjo announces date of 2020 year-end report and conference call

Arjo will issue its year-end report for 2020 on Wednesday February 3 at 07:00 CET, followed by a conference call at 08:00 CET, hosted by Joacim Lindoff, President & CEO, and Daniel Fäldt, CFO.

Réglementation
Communiqués de presse
Arjo Logo
Plus aucun résultat disponible